Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations.

The macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine central to the response to endotoxemia, is a putative biomarker in acute lung injury (ALI). To explore MIF as a molecular target and candidate gene in ALI, the MIF gene and protein expression were examined in murine and canine models of ALI (high tidal volume mechanical ventilation, endotoxin exposure) and in patients with either sepsis or sepsis-induced ALI. MIF gene expression and protein levels were significantly increased in each ALI model, with serum MIF levels significantly higher in patients with either sepsis or ALI compared with healthy controls (African- and European-descent). The association of 8 MIF gene polymorphisms (single-nucleotide polymorphisms (SNPs)) (within a 9.7-kb interval on chromosome 22q11.23) with the development of sepsis and ALI in European-descent and African-descent populations was studied next. Genotyping in 506 DNA samples (sepsis patients, sepsis-associated ALI patients, and healthy controls) revealed haplotypes located in the 3' end of the MIF gene, but not individual SNPs, associated with sepsis and ALI in both populations. These data, generated via functional genomic and genetic approaches, suggest that MIF is a relevant molecular target in ALI.

[1]  R. Bucala,et al.  Role for macrophage migration inhibitory factor in acute respiratory distress syndrome , 2003, The Journal of pathology.

[2]  P. Vineis,et al.  Bias and confounding in molecular epidemiological studies: special considerations. , 1998, Carcinogenesis.

[3]  Toshihiro Tanaka The International HapMap Project , 2003, Nature.

[4]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[5]  B. Simon,et al.  Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. , 2004, American journal of respiratory and critical care medicine.

[6]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[7]  A. Silman,et al.  Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis , 2003, Genes and Immunity.

[8]  D. Grigoryev,et al.  Science review: Searching for gene candidates in acute lung injury , 2004, Critical care.

[9]  L. Armstrong,et al.  Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome. , 1997, Thorax.

[10]  H. Shimizu,et al.  Macrophage Migration Inhibitory Factor Is Induced by Thrombin and Factor Xa in Endothelial Cells* , 2004, Journal of Biological Chemistry.

[11]  R. Bucala,et al.  Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome , 1997, Nature Medicine.

[12]  H. Rabb,et al.  Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. , 2004, American journal of respiratory and critical care medicine.

[13]  T. Calandra,et al.  Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4) , 2003, Journal of endotoxin research.

[14]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .

[15]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[16]  A. Verin,et al.  Adherent neutrophils activate endothelial myosin light chain kinase: role in transendothelial migration. , 1998, Journal of applied physiology.

[17]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[18]  E. Anderson Hudson et al. , 1977 .

[19]  N. Schork,et al.  Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. , 2001, Genome research.

[20]  T. Calandra,et al.  Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis. , 2003, The Journal of infectious diseases.

[21]  T. Standiford,et al.  Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. , 2005, American journal of respiratory and critical care medicine.

[22]  K. Tracey,et al.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia , 1993, Nature.

[23]  T. Calandra,et al.  Macrophage migration inhibitory factor: a regulator of innate immunity , 2003, Nature Reviews Immunology.

[24]  D. Mannino,et al.  Race and gender differences in acute respiratory distress syndrome deaths in the United States: An analysis of multiple-cause mortality data (1979–1996)* , 2002, Critical care medicine.

[25]  Arthur S Slutsky,et al.  Multiple system organ failure. Is mechanical ventilation a contributing factor? , 1998, American journal of respiratory and critical care medicine.

[26]  R. Jansen,et al.  mRNA localization: message on the move , 2001, Nature Reviews Molecular Cell Biology.

[27]  Sharon R Browning,et al.  Multilocus association mapping using variable-length Markov chains. , 2006, American journal of human genetics.

[28]  B. Simon,et al.  Microarray analysis of regional cellular responses to local mechanical stress in acute lung injury. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[29]  P. Gregersen,et al.  A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis , 2002, Genes and Immunity.

[30]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[31]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[32]  P. Ward,et al.  The enigma of sepsis. , 2003, The Journal of clinical investigation.

[33]  T. Hibi,et al.  Association of the −173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis , 2004, Journal of Gastroenterology.

[34]  Dan L Nicolae,et al.  Testing Untyped Alleles (TUNA)—applications to genome‐wide association studies , 2006, Genetic epidemiology.

[35]  T. Beaty,et al.  Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. , 2006, American journal of respiratory cell and molecular biology.

[36]  J. Mendell,et al.  When the Message Goes Awry Disease-Producing Mutations that Influence mRNA Content and Performance , 2001, Cell.

[37]  S. Kleeberger,et al.  Gene-environment interactions in asthma and other respiratory diseases. , 2005, Annual review of medicine.

[38]  D. Ray,et al.  Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. , 2004, The Journal of investigative dermatology.

[39]  P. Parsons Bridging the chasm between bench and bedside: translational research in acute lung injury. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[40]  M. Crow,et al.  Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[41]  J. Garcia,et al.  Intracellular interaction of myosin light chain kinase with macrophage migration inhibition factor (MIF) in endothelium , 2005, Journal of cellular biochemistry.

[42]  C. Flores,et al.  Genomics of acute lung injury. , 2006, Seminars in respiratory and critical care medicine.

[43]  E. Zeggini,et al.  Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. , 2002, Arthritis and rheumatism.

[44]  A. F. Scott,et al.  Variants in the gene encoding C3 are associated with asthma and related phenotypes among African Caribbean families , 2006, Genes and Immunity.

[45]  C. Ober,et al.  A variant of the myosin light chain kinase gene is associated with severe asthma in African Americans , 2007, Genetic epidemiology.

[46]  Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. , 2001, The Journal of clinical endocrinology and metabolism.

[47]  D. Prows,et al.  Genetic susceptibility to nickel-induced acute lung injury. , 2003, Chemosphere.

[48]  Joan Valls,et al.  SNPStats: a web tool for the analysis of association studies , 2006, Bioinform..

[49]  H. Davis,et al.  Regulation of endothelial cell gap formation and barrier dysfunction: Role of myosin light chain phosphorylation , 1995, Journal of cellular physiology.

[50]  R. Bucala,et al.  Macrophage migration inhibitory factor. , 2005, Critical care medicine.

[51]  M. Matthay,et al.  The acute respiratory distress syndrome. , 1996, The New England journal of medicine.

[52]  T. Calandra,et al.  Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  S. Dudek,et al.  Cytoskeletal regulation of pulmonary vascular permeability. , 2001, Journal of applied physiology.